HCA Healthcare (NYSE:HCA) Given New $535.00 Price Target at JPMorgan Chase & Co.

HCA Healthcare (NYSE:HCA) had its price objective hoisted by JPMorgan Chase & Co. from $420.00 to $535.00 in a note issued to investors on Friday,MarketScreener reports. JPMorgan Chase & Co.‘s target price indicates a potential upside of 1.52% from the stock’s current price.

Other equities analysts have also recently issued research reports about the stock. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Jefferies Financial Group boosted their target price on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Argus upped their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a report on Monday, December 15th. Finally, Truist Financial boosted their target price on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $530.77.

HCA Healthcare Trading Down 0.3%

Shares of NYSE:HCA traded down $1.70 during mid-day trading on Friday, reaching $526.97. The company had a trading volume of 66,868 shares, compared to its average volume of 1,099,007. The company’s 50-day moving average price is $487.04 and its 200-day moving average price is $453.28. HCA Healthcare has a one year low of $295.00 and a one year high of $552.90. The firm has a market cap of $117.84 billion, a price-to-earnings ratio of 18.61, a PEG ratio of 1.64 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the company posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts anticipate that HCA Healthcare will post 24.98 EPS for the current fiscal year.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This represents a 40.07% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the transaction, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. This represents a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 in the last quarter. 1.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Norges Bank bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $1,152,408,000. Pacer Advisors Inc. lifted its stake in shares of HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after buying an additional 896,437 shares in the last quarter. Life Cycle Investment Partners Ltd bought a new position in shares of HCA Healthcare in the fourth quarter worth about $374,037,000. Viking Global Investors LP boosted its stake in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after buying an additional 649,058 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.